Found 2 hits for monomerid = 50396249 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
ALK tyrosine kinase receptor
(Homo sapiens (Human)) | BDBM50396249
(CHEMBL2172334)Show SMILES CC(C)NC(=O)[C@H]1CC[C@H](CC1)n1c(NC(=O)c2ccc(F)cc2)nc2ccc(CN3CCNC(=O)C3)cc12 |r,wU:9.12,6.5,(19.95,-39.16,;18.45,-38.84,;17.97,-37.38,;17.42,-39.99,;15.91,-39.67,;14.88,-40.82,;15.43,-38.21,;13.93,-37.89,;13.45,-36.43,;14.48,-35.29,;15.98,-35.59,;16.46,-37.06,;14,-33.83,;14.9,-32.56,;16.44,-32.56,;17.2,-31.22,;16.42,-29.89,;18.74,-31.21,;19.52,-32.54,;21.05,-32.53,;21.82,-31.19,;23.36,-31.18,;21.03,-29.86,;19.5,-29.87,;13.98,-31.32,;12.51,-31.8,;11.17,-31.04,;9.84,-31.81,;9.84,-33.35,;8.51,-34.12,;7.17,-33.35,;5.84,-34.13,;4.51,-33.35,;4.51,-31.8,;5.85,-31.04,;5.86,-29.5,;7.17,-31.81,;11.18,-34.13,;12.52,-33.35,)| Show InChI InChI=1S/C29H35FN6O3/c1-18(2)32-27(38)21-6-10-23(11-7-21)36-25-15-19(16-35-14-13-31-26(37)17-35)3-12-24(25)33-29(36)34-28(39)20-4-8-22(30)9-5-20/h3-5,8-9,12,15,18,21,23H,6-7,10-11,13-14,16-17H2,1-2H3,(H,31,37)(H,32,38)(H,33,34,39)/t21-,23+ | PDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description Inhibition of ALK enzyme |
J Med Chem 55: 6523-40 (2012)
Article DOI: 10.1021/jm3005866 BindingDB Entry DOI: 10.7270/Q2M046KT |
More data for this Ligand-Target Pair | |
ALK tyrosine kinase receptor
(Homo sapiens (Human)) | BDBM50396249
(CHEMBL2172334)Show SMILES CC(C)NC(=O)[C@H]1CC[C@H](CC1)n1c(NC(=O)c2ccc(F)cc2)nc2ccc(CN3CCNC(=O)C3)cc12 |r,wU:9.12,6.5,(19.95,-39.16,;18.45,-38.84,;17.97,-37.38,;17.42,-39.99,;15.91,-39.67,;14.88,-40.82,;15.43,-38.21,;13.93,-37.89,;13.45,-36.43,;14.48,-35.29,;15.98,-35.59,;16.46,-37.06,;14,-33.83,;14.9,-32.56,;16.44,-32.56,;17.2,-31.22,;16.42,-29.89,;18.74,-31.21,;19.52,-32.54,;21.05,-32.53,;21.82,-31.19,;23.36,-31.18,;21.03,-29.86,;19.5,-29.87,;13.98,-31.32,;12.51,-31.8,;11.17,-31.04,;9.84,-31.81,;9.84,-33.35,;8.51,-34.12,;7.17,-33.35,;5.84,-34.13,;4.51,-33.35,;4.51,-31.8,;5.85,-31.04,;5.86,-29.5,;7.17,-31.81,;11.18,-34.13,;12.52,-33.35,)| Show InChI InChI=1S/C29H35FN6O3/c1-18(2)32-27(38)21-6-10-23(11-7-21)36-25-15-19(16-35-14-13-31-26(37)17-35)3-12-24(25)33-29(36)34-28(39)20-4-8-22(30)9-5-20/h3-5,8-9,12,15,18,21,23H,6-7,10-11,13-14,16-17H2,1-2H3,(H,31,37)(H,32,38)(H,33,34,39)/t21-,23+ | PDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 6 | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description Inhibition of ALK Tyr1604 phosphorylation by cell based assay |
J Med Chem 55: 6523-40 (2012)
Article DOI: 10.1021/jm3005866 BindingDB Entry DOI: 10.7270/Q2M046KT |
More data for this Ligand-Target Pair | |